News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News Tax breaks could nurture UK’s cell and gene therapy manufact... Tax breaks for R&D and innovative manufacturing could be part of life sciences strategy.
News NHS set to lose out to Brexit in budget Brexit bill and debt levels make spending spree unlikely, says Chancellor
News Lords defy government with post-Brexit guarantee for EU nati... Peers introduce amendment to Brexit bill.
News Thousands of doctors could quit UK because of Brexit Four in ten EEA doctors considering quitting, says survey.
News Norgine rejoins ABPI after eight year absence ABPI says Norgine's support will be important during Brexit.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.